• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization.

作者信息

Kim K W, Chung S, Lee S Y, Yoon S S, Kang H R

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.

出版信息

J Investig Allergol Clin Immunol. 2020;30(6):457-459. doi: 10.18176/jiaci.0581. Epub 2020 May 6.

DOI:10.18176/jiaci.0581
PMID:32376522
Abstract
摘要

相似文献

1
Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization.通过脱敏成功输注奥滨尤妥珠单抗：一例脱敏过程中发生过敏性休克的病例
J Investig Allergol Clin Immunol. 2020;30(6):457-459. doi: 10.18176/jiaci.0581. Epub 2020 May 6.
2
Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.肺腺癌治疗中严重过敏反应后阿替利珠单抗和贝伐单抗脱敏方案
J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):265-267. doi: 10.18176/jiaci.0637. Epub 2020 Aug 26.
3
Protocol for Desensitization to Trastuzumab in a Patient With Anaphylaxis and Stage IV Breast Cancer: A Case Report.一例IV期乳腺癌伴过敏反应患者的曲妥珠单抗脱敏方案：病例报告
J Investig Allergol Clin Immunol. 2020;30(5):376-377. doi: 10.18176/jiaci.0558. Epub 2020 May 6.
4
Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization.难治性多发性骨髓瘤合并惰性系统性肥大细胞增多症患者对isatuximab成功脱敏。回复：isatuximab导致过敏性休克及成功脱敏
J Investig Allergol Clin Immunol. 2024 Jun;34(3):214-216. doi: 10.18176/jiaci.0990.
5
Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization.免疫检查点抑制剂单克隆抗体致超敏反应和过敏反应及脱敏治疗
Ann Allergy Asthma Immunol. 2021 Jun;126(6):623-629. doi: 10.1016/j.anai.2021.03.008. Epub 2021 Mar 26.
6
Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.对帕妥珠单抗过敏后嗜碱性粒细胞活化试验呈阳性，以及快速脱敏成功治疗。
J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):338-40. doi: 10.1016/j.jaip.2015.10.007. Epub 2015 Dec 24.
7
Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment.在奥马珠单抗预处理后，对患有法布里病且出现β-半乳糖苷酶（法布赞）过敏反应的患者成功进行脱敏治疗。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):96-98. doi: 10.1016/j.anai.2020.08.026. Epub 2020 Aug 29.
8
Successful rapid tocilizumab desensitization in a patient with Still disease.一名斯蒂尔病患者成功进行了快速托珠单抗脱敏治疗。
J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):631-2. doi: 10.1016/j.jaip.2014.04.015. Epub 2014 Jun 2.
9
Eculizumab hypersensitivity and desensitization in a toddler with atypical hemolytic uremic syndrome.一名非典型溶血尿毒综合征幼儿的依库珠单抗超敏反应及脱敏治疗
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2409-2410. doi: 10.1016/j.jaip.2019.03.027. Epub 2019 Apr 1.
10
Effective desensitization to imiglucerase in a patient with type I Gaucher disease.对 1 型戈谢病患者进行伊米苷酶的有效脱敏。
J Pediatr. 2009 Dec;155(6):940-1. doi: 10.1016/j.jpeds.2009.05.033.

引用本文的文献

1
Successful Switch to Obinutuzumab in a Rituximab-Intolerant Child with Difficult-to-Treat Idiopathic Nephrotic Syndrome.一名对利妥昔单抗不耐受的难治性特发性肾病综合征儿童成功转换为使用奥妥珠单抗治疗
J Clin Med. 2025 Jan 3;14(1):239. doi: 10.3390/jcm14010239.
2
Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature.卡瑞利珠单抗致食管鳞状细胞癌患者过敏性休克：一例报告并文献复习
World J Clin Cases. 2022 Jun 26;10(18):6198-6204. doi: 10.12998/wjcc.v10.i18.6198.